Atacand and Rosiglitazone maleate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Atacand and Rosiglitazone maleate together.

The phase IV clinical study analyzes what interactions people who take Atacand and Rosiglitazone maleate have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 18, 2023

2 people who take Atacand and Rosiglitazone maleate together, and have interactions are studied.


What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 21,793 Atacand users for its effectiveness, alternative drugs and more.

What is Rosiglitazone maleate?

Rosiglitazone maleate has active ingredients of rosiglitazone maleate. eHealthMe is studying from 2,980 Rosiglitazone maleate users for its effectiveness, alternative drugs and more.

Number of Atacand and Rosiglitazone maleate reports submitted per year:

Atacand and Rosiglitazone maleate drug interactions.

Common Atacand and Rosiglitazone Maleate drug interactions by gender *:

female:

  1. Diarrhoea
  2. Dizziness
  3. Amnesia
  4. Anaemia
  5. Anxiety
  6. Aortic arteriosclerosis
  7. Aortic calcification
  8. Aortic valve incompetence
  9. Arthralgia
  10. Atelectasis

male:

n/a

Common Atacand and Rosiglitazone Maleate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Amnesia
  2. Seroma
  3. Sinus disorder
  4. Skin ulcer
  5. Sleep apnoea syndrome
  6. Anaemia
  7. Anxiety
  8. Aortic arteriosclerosis
  9. Aortic calcification
  10. Aortic valve incompetence

60+:

  1. Asthenia
  2. Blood creatine phosphokinase increased
  3. Blood creatinine increased
  4. Blood pressure decreased
  5. Diarrhoea
  6. Dizziness
  7. Fatigue
  8. Nocturia

* Approximation only. Some reports may have incomplete information.

Do you take Atacand and Rosiglitazone maleate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Atacand and Rosiglitazone maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atacand side effects:

Browse all side effects of Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rosiglitazone maleate side effects:

Browse all side effects of Rosiglitazone maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atacand interactions:

Browse all interactions between Atacand and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rosiglitazone maleate interactions:

Browse all interactions between Rosiglitazone maleate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil and rosiglitazone maleate (the active ingredients of Atacand and Rosiglitazone maleate, respectively), and Atacand and Rosiglitazone maleate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Atacand and Rosiglitazone maleate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: